Skip to content

Thoracoscopic Pleural Biopsy in Sohag University Hospital

Thoracoscopic Pleural Biopsy, Sohag University Hospital

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06964308
Enrollment
36
Registered
2025-05-09
Start date
2024-10-01
Completion date
2025-05-30
Last updated
2025-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pleural Diseases

Brief summary

This study aims to evaluate the diagnostic efficacy, safety, and clinical outcomes of thoracoscopic pleural biopsy in the management of pleural diseases.

Interventions

PROCEDUREthoracoscopic pleural biopsy.

This intervention aims to evaluate the diagnostic efficacy, safety, and clinical outcomes of thoracoscopic pleural biopsy in the management of pleural diseases.

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with suspected pleural disease who have been referred for thoracoscopic pleural biopsy * Age: Adults aged 18 years and older * Patients should have undergone necessary preoperative evaluations, including imaging studies (e.g., chest X-ray, CT scan) that indicate a need for biopsy.

Exclusion criteria

* Contraindications to Thoracoscopic Biopsy: Patients with contraindications to thoracoscopic biopsy * Infeasibility of Procedure: Patients with anatomical or physiological factors that make thoracoscopic biopsy technically unfeasible or unsafe (e.g., severe pleural adhesions or distorted anatomy). * Alternative Diagnoses: Patients who have been definitively diagnosed with a condition that does not require thoracoscopic biopsy for further evaluation. * Pregnancy: Pregnant women may be excluded due to potential risks to the fetus and the need for specific procedural considerations. * Inability to Provide Consent: Patients who are unable to provide informed consent due to cognitive impairment, language barriers, or other reasons. * Participation in Concurrent Studies: Patients currently participating in other clinical studies that could interfere with the outcomes of this study or affect their eligibility.

Design outcomes

Primary

MeasureTime frameDescription
early postoperative follow up for thoracoscopic pleural biopsy in the management of pleural diseases.3 days after procedurereturn to daily activity

Countries

Egypt

Contacts

Primary ContactAhmed O Yehya, Resident
ahmedosamayehya37@yahoo.com01146628670
Backup Contactessam A mokhtar, Professor
01011908152

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026